NeuroMetrix Plans Strategic Options To Promote Growth, Maxim

On Tuesday, medical device company NeuroMetrix, Inc. (NURO) said that it has reviewed strategic options for the growth of its Quell neuromodulation and DPNCheck neurodiagnostic businesses with maximum shareholder value.

Related Keywords

Shai Gozani , Nasdaq , Ladenburg Thalmann Co , Neurometrix Inc , Medicare Advantage , Ladenburg Thalmann , Growth , Medical Device , Eurometrix , Eurodiagnostic , Pncheck , Uell Neuromodulation ,